TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 1 | -0 | -3 | 8 | 36 | 89 | 22 |
| S | %wins | 33 | 100 | 100 | 33 | 0 | 0 | 44 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/3/15 11:32 | 9/3/15 | HSP | Hospira Inc | DE | Health | Drug | Pharmaceutical Preparations | Endicott David J. | IL | O | P,Hospir | M.d | 3,138 | 43.01 | 0 | 73 | 0 | D | |||||||||||||||
1/23/13 18:40 | 11/29/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Endicott David J. | CA | O | CVP,P,AG | M.ad | 125 | 64.47 | 33 | 2 | 9 | 23 | D | 63 | 41 | 11 | -3 | -4 | -1 | -3 | 1 | 1 | 0 | -2 | 15 | 48 | 117 |
1/23/13 18:40 | 11/29/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Endicott David J. | CA | O | CVP,P,AG | S.ad | -179 | 92.33 | 33 | -2 | -8 | 23 | D | 63 | 41 | 11 | -3 | -4 | -1 | -3 | 1 | 1 | 0 | -2 | 15 | 48 | 117 |
11/30/12 17:33 | 11/29/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Endicott David J. | CA | O | CVP,P,AG | M.d | 3,389 | 64.47 | 33 | 53 | 23 | D | 79 | 33 | 21 | 6 | -2 | 2 | 3 | 1 | 0 | 0 | -2 | -2 | 41 | 86 | |
11/30/12 17:33 | 11/29/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Endicott David J. | CA | O | CVP,P,AG | S.d | -4,858 | 92.43 | 33 | -53 | -69 | 23 | D | 79 | 33 | 21 | 6 | -2 | 2 | 3 | 1 | 0 | 0 | -2 | -2 | 41 | 86 |
5/9/12 19:25 | 5/7/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Endicott David J. | CA | O | CVP,P,AG | M.d | 1,342 | 48.78 | 33 | 28 | 24 | D | 78 | 17 | 14 | 28 | 11 | 9 | -3 | -1 | 1 | -1 | -5 | 10 | 20 | 64 | |
5/9/12 19:25 | 5/7/12 | AGN | Allergan Inc | DE | Health | Drug | Pharmaceutical Preparations | Endicott David J. | CA | O | CVP,P,AG | S.d | -2,580 | 93.81 | 33 | -28 | -53 | 24 | D | 78 | 17 | 14 | 28 | 11 | 9 | -3 | -1 | 1 | -1 | -5 | 10 | 20 | 64 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |